BMO Capital Starts Radient Pharmaceuticals (RPC) at Outperform
Tweet
Share
E-mailGet Alerts RPC Hot Sheet
Price: $8.42 +1.20%
Rating Summary:
2 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 12 | New: 5
Rating Summary:
2 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 12 | New: 5
Join SI Premium – FREE
BMO Capital initiates coverage on Radient Pharmaceuticals (NYSE: RPC) with a Outperform rating and a price target of $24.00.
For an analyst ratings summary and ratings history on Radient Pharmaceuticals click here. For more ratings news on Radient Pharmaceuticals click here.
Shares of Radient Pharmaceuticals closed at $0.21 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Freedom Broker Starts Intrepid Potash (IPI) at Buy
- Mizuho Starts SunocoCorp LLC (SUNC) at Outperform
- Goldman Sachs Starts SJS Enterprises Ltd (SJS:IN) at Buy
Create E-mail Alert Related Categories
New CoverageRelated Entities
BMO CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
